000341014 000__ 02254cam\a22004814a\4500
000341014 001__ 341014
000341014 005__ 20220217104009.0
000341014 008__ 060825s2006\\\\dcua\\\\\b\\\f000\0\eng\c
000341014 010__ $$a  2006460628
000341014 020__ $$a0160758777
000341014 020__ $$a9780160758775
000341014 035__ $$a(OCoLC)ocm64445479
000341014 035__ $$a(OCoLC)64445479
000341014 035__ $$a341014
000341014 037__ $$a552-070-33883-7$$bGPO
000341014 040__ $$aSEN$$cSEN$$dDLC$$dBTCTA
000341014 042__ $$apcc
000341014 043__ $$an-us---
000341014 049__ $$aISEA
000341014 05000 $$aRM880$$b.C66 2005
000341014 074__ $$a1038-A
000341014 074__ $$a1038-A (online)
000341014 074__ $$a1038-B (MF)
000341014 074__ $$a1038-B (online)
000341014 08200 $$a362.2/5$$222
000341014 0860_ $$aY 4.F 49:S.PRT.109-45
000341014 24500 $$aCommittee staff report to the chairman and ranking member :$$breview of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression /$$cprepared by the staff of the Committee on Finance, United States Senate ; Charles E. Grassley, chairman, Max Baucus, ranking member.
000341014 24630 $$aReview of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression
000341014 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., U.S. G.P.O.,$$c2006.
000341014 300__ $$aiv, 386 p. :$$bill. ;$$c23 cm.
000341014 440_0 $$aS. prt. ;$$v109-45
000341014 500__ $$aAt head of title: 109th Congress, 2d session, Committee print.
000341014 500__ $$a"Printed for the use of the Committee on Finance."
000341014 500__ $$aDistributed to some depository libraries in microfiche.
000341014 500__ $$aShipping list no.: 2006-0141-P.
000341014 504__ $$aIncludes bibliographical references.
000341014 530__ $$aAlso available via Internet from the Finance Committee web site. Address as of 4/27/06: http://finance.senate.gov/press/Gpress/02%5F2006%20report.pdf; current access available via PURL.
000341014 61010 $$aUnited States.$$bFood and Drug Administration$$vRules and practice.
000341014 650_0 $$aTranscutaneous electrical nerve stimulation$$xTherapeutic use$$xGovernment policy$$zUnited States.
000341014 650_0 $$aDepression, Mental$$xTreatment$$xGovernment policy$$zUnited States.
000341014 650_0 $$aVagus nerve.
000341014 7101_ $$aUnited States.$$bCongress.$$bSenate.$$bCommittee on Finance.
000341014 85230 $$bdfich$$hY 4.F 49:$$iS.PRT.109-45
000341014 85641 $$uhttp://purl.access.gpo.gov/GPO/LPS69295
000341014 909CO $$ooai:library.usi.edu:341014$$pGLOBAL_SET
000341014 980__ $$aBIB
000341014 980__ $$aGOV RESOURCE